Home / Products / Cancer (Tumor) Cell Lines / NCI-H1048
NCI-H1048
Datasheet Protocol

NCI-H1048

Cat. No. ARC0559
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Lung

Growth Properties:

Adherent

In stock
$2,300.00 / Vial
Ask a Question

Short Description 🔒

NCI-H1048 is a cancer cell line of small cell lung cancer (SCLC), isolated from metastatic; pleural effusion.

Recommended Products

MYOF Knockout K562 Polyclonal Cells MYOF Knockout K562 Polyclonal Cells Cat. No. ARG19386 ERN1 Knockout Lovo Polyclonal Cells ERN1 Knockout Lovo Polyclonal Cells Cat. No. ARG11675 MAN2B2 Knockout Hela Polyclonal Cells MAN2B2 Knockout Hela Polyclonal Cells Cat. No. ARG9105 ACAP1 Knockout A2780 Polyclonal Cells ACAP1 Knockout A2780 Polyclonal Cells Cat. No. ARG28568 INF2 Knockout jurkat Polyclonal Cells INF2 Knockout jurkat Polyclonal Cells Cat. No. ARG34336 GSDMA Knockout Hela Polyclonal Cells GSDMA Knockout Hela Polyclonal Cells Cat. No. ARG37612
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Lung
Disease:
Small cell lung cancer (SCLC)
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
53 years
Sex of Donor:
Female
Derived From Site:
Metastatic; Pleural effusion
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

ACTN4 Knockout Raji Polyclonal Cells

ACTN4 Knockout Raji Polyclonal Cells

Cat. No. ARG21053
 BUB1 Knockout HT29 Polyclonal Cells

BUB1 Knockout HT29 Polyclonal Cells

Cat. No. ARG23300
 LUC7L Knockout AGS Polyclonal Cells

LUC7L Knockout AGS Polyclonal Cells

Cat. No. ARG3230
 MAP3K7 Knockout AGS Polyclonal Cells

MAP3K7 Knockout AGS Polyclonal Cells

Cat. No. ARG2691
 EPHB6 Knockout Raji Polyclonal Cells

EPHB6 Knockout Raji Polyclonal Cells

Cat. No. ARG1777
 FGFR4 Knockout Raji Polyclonal Cells

FGFR4 Knockout Raji Polyclonal Cells

Cat. No. ARG1240